glutathione and triple negative breast cancer Targeting the redox-programmed cell death axis in cancer: from molecular mechanisms to therapeutic resistance A review of biological targets
A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect CD36 enhances sensitivity of triple negative breast cancer cells to palmitate induced ferroptosis Cell Death & Disease Comprehensive single cell metabolic profiling identifies targets to sensitize triple negative breast cancer to chemo immunotherapy: Cell Reports Medicine
Pay in 4 interest-free payments of $5.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23





